Chief scientific officer Philip Dormitzer denied the company should have developed a more potent jab

Read a transcript of this episode on FT.com

https://www-ft-com.ezp-prod1.hul.harvard.edu/content/7a545b87-55eb-4dbd-b9a0-c80def4bdcf8


Pfizer’s chief scientific officer Philip Dormitzer denied that the company should have developed a more potent Covid-19 vaccine, and the Taliban has announced Afghanistan’s first government since the US left the country, and James Bullard, president of the St Louis Fed pushed back on concerns that the US labour market recovery is faltering. Plus, the FT’s Beijing bureau chief, Tom Mitchell, explains whether China is heading into a new political era under president Xi Jinping. 


Top Pfizer scientist defends booster push and vaccine potency

https://www-ft-com.ezp-prod1.hul.harvard.edu/content/3ee3efaa-766c-42c9-baf7-9825d3e78edf


Taliban announces government as it faces growing crises and isolation

https://www-ft-com.ezp-prod1.hul.harvard.edu/content/9cc0e2ca-19ab-4614-a168-76f1e4c1875b


Top Fed official pushes for quick ‘taper’ despite weak US jobs growth

https://www-ft-com.ezp-prod1.hul.harvard.edu/content/7c2fc0ce-e7c0-4083-92e8-e81d9235ab45


The Chinese control revolution: the Maoist echoes of Xi’s power play

https://www-ft-com.ezp-prod1.hul.harvard.edu/content/bacf9b6a-326b-4aa9-a8f6-2456921e61ec


The FT News Briefing is produced by Fiona Symon and Marc Filippino. The show’s editor is Jess Smith. Additional help by Gavin Kallmann, Michael Bruning, and Persis Love. The show’s theme song is by Metaphor Music. The FT’s global head of audio is Cheryl Brumley. 



See acast.com/privacy for privacy and opt-out information.

Transcripts are not currently available for all podcasts, view our accessibility guide.

Get alerts on FT News Briefing when a new story is published

Copyright The Financial Times Limited 2021. All rights reserved.
Reuse this content (opens in new window) CommentsJump to comments section

Comments have not been enabled for this article.